Molbio Diagnostics made a strong stock market debut, listing at a 21.44% premium over its IPO price of Rs 807. The Rs 939.70 crore IPO was subscribed 70.26 times, led by QIBs. The company plans to use IPO proceeds to expand its R&D, manufacturing infrastructure and strengthen its diagnostics capabilities.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.